Menlo Park, CA, United States of America

Kenan Christopher Garcia

This inventor holds 41 USPTO granted patents and 51 published patent applications, plus 5 CIPO patents and 5 EPO patents, primarily in Cytokine Engineering. Top assignees: Leland Stanford Junior University, University of Washington, California Institute of Technology. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenan Christopher Garcia. Retrieved from https://idiyas.com/inventor/kenan-christopher-garcia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 41 (Patent Applications = 51)

% Patents Active = 100.0

CIPO Patents = 5 (Patent Applications = 24)

EPO Patents = 5 (Patent Applications = 37)

Average Co-Inventor Count = 3.6

ph-index = 6

Forward Citations = 132(Granted Patents)

Location History:

Seattle, WA (US) (2020)
Stanford, CA (US) (2020 - 2023)
Menlo Park, CA (US) (2016 - 2024)

Company Filing History:

39 out of 5,512

Leland Stanford Junior University

patents

11 out of 2,172

University of Washington

patents

4 out of 4,626

California Institute of Technology

patents

4. 3 out of 4

Parker Institute for Cancer Immunotherapy

University of California

patents

7. 1 out of 309

Fred Hutchinson Cancer Center

patents

8. 1 out of 12

Medicenna Therapeutics, Inc.

patents

where one patent can have more than one assignee

Years Active: 2016-2026

Loading Chart...

Areas of Expertise:

Cytokine

Interleukin

SIRP-alpha

Superagonist

Therapeutic Polypeptide

Ligand Discovery

T Cell Receptor

Biologically Relevant

Partial Agonist

Engineered Protein

WNT Signaling

Anti-IL-2 Antibody

41 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12590133 - IL-13/IL-4 SUPERKINES: IMMUNE CELL TARGETING CONSTRUCTS AND METHODS OF USE THEREOF (2026-03-31),

2. 12466868 - ENGINEERED PROTEINS TO ENHANCE SENSITIVITY OF A CELL TO IL-2 (2025-11-11),

3. 12410226 - Interferon-gamma biased agonists (2025-09-09),

4. 12240880 - De novo design of potent and selective interleukin mimetics (2025-03-04),

5. 12227553 - De novo design of potent and selective interleukin mimetics (2025-02-18),

6. 12221469 - Switch receptors using IL-9 signaling domains (2025-02-11),

7. 12195532 - High affinity SIRP-alpha reagents and methods of using (2025-01-14),

8. 12091441 - Partial agonists of interleukin-2 (2024-09-17),

9. 12084684 - Frizzled specific Wnt agonists and antagonists (2024-09-10),

10. 12006347 - Superagonists and antagonists of interleukin-2 (2024-06-11),

11. 12005079 - Biologically relevant orthogonal cytokine/receptor pairs (2024-06-11),

12. 11993645 - Compositions comprising R-Spondin (RSPO) surrogate molecules (2024-05-28),

13. 11993639 - Therapeutic IL-13 polypeptides (2024-05-28),

14. 11846639 - Ligand discovery for T cell receptors (2023-12-19),

15. 11780899 - Engineered proteins to enhance sensitivity of a cell to IL-2 (2023-10-10),

Title: Kenan Christopher Garcia - Innovative Inventor from Menlo Park

Introduction: Kenan Christopher Garcia is a talented inventor based in Menlo Park, California, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Kenan Christopher Garcia holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and creativity.

Career Highlights: With a background in engineering and a passion for problem-solving, Kenan Christopher Garcia has successfully developed cutting-edge solutions that have revolutionized various industries. His innovative approach has led to the creation of products that have significantly impacted the way we live and work.

Collaborations: Throughout his career, Kenan Christopher Garcia has collaborated with leading researchers, engineers, and scientists to bring his ideas to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Kenan Christopher Garcia's relentless pursuit of innovation and his commitment to pushing the boundaries of what is possible make him a true visionary in the world of inventions. His work continues to inspire and shape the future of technology.

Profile summary based on public USPTO records.